Sepsis Mortality in CIITA Deficient Mice is Associated with Excessive Release of High-mobility Group Box 1
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: Down regulation of major histocompatibility complex class II transactivator (CIITA) has been identified as a major factor of immunosuppression in sepsis and the level of CIITA expression inversely correlates with the degree of severity. However, it has not been fully elucidated whether the lower expression of CIITA is a cause of disease process or a just associated sign. Here we determined whether the CIITA deficiency decreased survival rate using murine sepsis model. Methods: Major histocompatibility complex class II (MHC-II) deficient, CIITA deficient and wild type B6 mice were subjected to cecal ligation puncture (CLP) surgery. CIITA and recombination activation gene (RAG)-1 double deficient mice were generated to test the role of lymphocytes in CIITA-associated sepsis progression. Results: Sepsis mortality was enhanced in CIITA deficient mice, not by impaired bacterial clearance resulted from CD4 T cell depletion, but hyper-inflammatory response such as excessive release of a pro-inflammatory cytokine, high-mobility group box 1 (HMGB1). Conclusion: Our results demonstrate that CIITA deficiency affects the course of sepsis via the unexpected function of CIITA, regulation of cytokine release.
Abstract
Background: Down regulation of major histocompatibility complex class II transactivator (CIITA) has been identified as a major factor of immunosuppression in sepsis and the level of CIITA expression inversely correlates with the degree of severity. However, it has not been fully elucidated whether the lower expression of CIITA is a cause of disease process or a just associated sign. Here we determined whether the CIITA deficiency decreased survival rate using murine sepsis model. Methods: Major histocompatibility complex class II (MHC-II) deficient, CIITA deficient and wild type B6 mice were subjected to cecal ligation puncture (CLP) surgery. CIITA and recombination activation gene (RAG)-1 double deficient mice were generated to test the role of lymphocytes in CIITA-associated sepsis progression. Results: Sepsis mortality was enhanced in CIITA deficient mice, not by impaired bacterial clearance resulted from CD4 T cell depletion, but hyper-inflammatory response such as excessive release of a pro-inflammatory cytokine, high-mobility group box 1 (HMGB1). Conclusion: Our results demonstrate that CIITA deficiency affects the course of sepsis via the unexpected function of CIITA, regulation of cytokine release.
참고문헌 (26)
- Sessler CN, "New concepts in sepsis", Curr Opin Crit Care, 8, pp.465~472 (2002)
- Martin GS, "The epidemiology of sepsis in the United States from 1979 through 2000", N Engl J Med, 348, pp.1546~1554 (2003)
- Annane D, "Septic shock", Lancet, 365, pp.63~78 (2005)
- Reinhart K, "Anti-tumor necrosis factor therapy in sepsis: Update on clinical trials and lessons learned", Crit Care Med, 29, pp.S121~S125 (2001)
- Wang H, "HMG-1 as a late mediator of endotoxon lethality in mice", Science, 285, pp.248~251 (1999)
- Lotze MT, "High-mobility group box 1 protein (HMGB1): Nuclear weapon in the immune arsenal", Nat Rev Immunol, 5, pp.331~342 (2005)
- Yang H, "High mobility group box 1", Crit Care Med, 33, pp.S472~S474 (2005)
- Ulloa L, "High-mobility group box 1 (HMGB1) protein: Friend and foe", Cytokine Growth Factor Rev, 17, pp.189~201 (2006)
- Qin S, "Role of HMGB1 in apoptosis-mediated sepsis lethality", J Exp Med, 203, pp.1637~1642 (2006)
- Ting JP, "Genetic expression of MHC class II expression", Cell, 109, pp.S21~S33 (2002)
- Reith W, "Regulation of MHC class II gene expression by the class II transactivator", Nat Rev Immunol, 5, pp.793~806 (2005)
- Gourley T, "A novel role for the major histocompatibility complex class II transactivator CIITA in the repression of IL-4 production", Immunity, 10, pp.377~386 (1999)
- Zhu XS, "A 36-amino-acid region of CIITA is an effective inhibitor of CBP: novel mechanism of gamma interferon-mediated suppression of collagen alpha(2)(I) and other promoters", Mol Cell Biol, 21, pp.7078~7088 (2001)
- Butticé G, "Interferon-γ induces major histocompatibility class II transactivator (CIITA), which mediates collagen repression and major histocompatibility class II activation by human aortic smooth muscle cells", Circ Res, 98, pp.472~479 (2006)
- Gourley TS, "Aberrant expression of Fas ligand in mice deficient for the MHC class II transactivator", J Immunol, 168, pp.4414~4419 (2002)
- Wong AW, "CIITA-regulated plexin-A1 affects T-cell-dendritic cell interactions", Nat Immunol, 4, pp.891~898 (2003)
- Le Tulzo Y, "Monocyte human leukocyte antigen-DR transcriptional downregulation by cortisol during septic shock", Am J Respir Crit Care Med, 169, pp.1144~1151 (2004)
- Pachot A, "Messenger RNA expression of major histocompatibility complex class II genes in whole blood from septic shock patients", Crit Care Med, 33, pp.31~38 (2005)
- Yan JJ, "Therapeutic effects of lysophosphatidylcholine in experimental sepsis", Nat Med, 10, pp.161~167 (2004)
- Buras JA, "Animal mocel of sepsis: Setting the stage", Nat Rev Drug Discov, 4, pp.854~865 (2005)
- Gourley TS, "The class II transactivator prevents activation-induced cell death by inhibiting Fas ligand gene expression", J Immunol, 166, pp.2917~2921 (2001)
- Hotchkiss RS, "Apoptosis and caspases regulate death and inflammation in sepsis", Nat Rev Immunol, 6, pp.813~822 (2006)
- Fumeaux T, "Role of interleukin-10 in the intracellular sequestration of human leukocyte antigen-DR in monocytes during septic shock", Am J Respir Crit Care Med, 166, pp.1475~1482 (2002)
- Marchant A, "Interleukin-10 controls interferon-γ and tumor necrosis factor production during experimental endotoxemia", Eur J Immunol, 24, pp.1167~1171 (1994)
- Standiford TJ, "Neutralization of IL-10 increases lethality in endotoxemia: cooperative effects of macrophage inflammatory protein-2 and tumor necrosis factor", J. Immunol, 155, pp.2222~2229 (1995)
- Sewnath ME, "IL-10-deficient mice demonstrate multiple organ failure and increased mortality during Escherichia coli peritonitis despite an accelerated bacterial clearance", J immunol, 166, pp.6323~6331 (2001)